Advertisement
Loading...

Oncolytics Biotech Inc.

ONCY•NASDAQ
Healthcare
Biotechnology
$0.83
$0.03(4.05%)
U.S. Market is Open • 15:11

Oncolytics Biotech Inc. (ONCY) Stock Overview

Explore Oncolytics Biotech Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap77.8M
P/E Ratio-3.51
EPS (TTM)$-0.30
ROE51.32%
Fundamental Analysis

AI Price Forecasts

1 Month$1.11
3 Months$1.04
1 Year Target$0.95

ONCY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Oncolytics Biotech Inc. (ONCY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 31.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.51 and a market capitalization of 77.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.14%
5-Day Change
-10.92%
1-Month Change
-30.80%
3-Month Change
-22.50%
6-Month Change
-25.48%
Year-to-Date (YTD) Change
-11.33%
1-Year Change
74.31%
3-Year Change
-55.46%
5-Year Change
-72.61%
All-Time (Max) Change
-98.42%

Contact Information

https://www.oncolyticsbiotech.com
14036707380
322 11th Avenue SW, Calgary, AB, T2R 0C5

Company Facts

28 Employees
IPO DateOct 5, 2001
CountryCA
Actively Trading

Frequently Asked Questions